DMC Biotechnologies is a U.S. synthetic biology company using precision fermentation to make specialty chemicals from renewable feedstocks. Its Dynamic Metabolic Control„¢ technology allows bio-based production of nutraceuticals, cosmetic actives and performance chemicals such as D-chiro inositol and myo inositol. The company's mission is to transform chemical manufacturing through sustainable fermentation and reduce reliance on petroleum-derived inputs. DMC notes that its processes can cut carbon emissions by over 90€¯% versus conventional supply chains and provide resilient domestic supply. Headquartered in Morrisville, North Carolina, it collaborates with partners to accelerate product development, scale-up and commercial manufacturing.